top of page
Colorful Book Spines


Explore our list of published work below. Contact us to receive more information about the work that we do.


Patel T, Ivo J, Pitre T, Faisal S, Antunes K, Kasumi O. An In-Home Medication Dispensing System to Support Medication Adherence for Patients With Chronic Conditions in the Community Setting: Prospective Observational Pilot Study. JMIR Form Res. 2022;6(5):e34906

Patel T, Ivo J, McDougall A, Lee C, Chang L, Carducci J, Pritchard S. Development of a Clinician Guide for Electronic Medication Adherence Products in Older Adults. Can Pharm J. 2022;155(2):119-127

Faisal S, Ivo J, Tennant R, Prior K, Grindrod K, McMillan C, Patel T. Integration of a smart multidose blister package for medication intake: A mixed method ethnographic informed study of older adults with chronic diseasesPLoS One.  2022;17(1):e0262012

Faisal S, Ivo J, McMillan C, Grindrod K, Patel T. In-home medication management by older adults: a modified ethnography study using digital photography walkaboutsAge Ageing. 2022;51(1):afab207

Faisal S. Lessons in reflexivity of a pharmacist conducting ethnography. Res Social Adm Pharm. 2021;17(10):1849-1855

Patel T. Medication nonadherence: Time for a proactive approach by pharmacists. Can Pharm J. 2021; 154(5):292-296

Faisal S, Ivo J, Patel T. A review of features and characteristics of smart adherence products. Can Pharm J. 2021;154(5):312-323

Lee C, Ivo J, Carter C, Faisal S, Shao YW, Patel T. Pharmacist interventions for persons with intellectual disabilities: A scoping review. Res Social Adm Pharm. 2021;17(2):257–72.

Patel T, McDougall A, Ivo J, Carducci J, Pritchard S, Chang F, et al. Development and content validation of an instrument to measure medication self-management in older adults. Pharmacy. 2021;9(2):78.

Faisal S, Ivo J, Tennant R, Prior KA, Grindrod K, McMillan C, Patel T. Implementation of a real-time medication intake monitoring technology intervention in community pharmacy settings: A mixed-method pilot study. Pharmacy. 2021;9(2):105

Chen M, Patel T, Chang F. The impact of a primary care, pharmacist-driven intervention in patients with chronic non-cancer pain—A pilot study. Pharmacy. 2020;8(3):113.

Faisal S, Ivo J, Lee C, Carter C, Patel T. The usability, acceptability, and functionality of smart oral multidose dispensing systems for medication adherence: A scoping review. J Pharm Pract. 2020;35(8).

Faisal S, Ivo J, McDougall A, Patel T. Stakeholder feedback of electronic medication adherence products: Qualitative analysis. J Med Internet Res. 2020;22(12).

Patel T, Grindrod KA. Antiseizure drugs and women: Challenges with contraception and pregnancy. Can Pharm J. 2020;153(6):357–60.

Patel T, Grindrod KA. Antiseizure drugs in women with epilepsy: Use before, during, and after pregnancy. Can Pharm J. 2020;66(4):266–9.

Patel T, Hasan S, Chang F, McFarlane T. Controlled substances in hospices after patient death: a cross-sectional survey of Ontario hospices. Int J Clin Pharm. 2020;42(5):1344–53.


Patel T, Ivo J, Faisal S, McDougall A, Carducci J, Pritchard S, et al. A prospective study of usability and workload of electronic medication adherence products by older adults, caregivers, and health care providers. J Med Internet Res. 2020;22(6).


Tabeefar H, Chang F, Cooke M, Patel T. Community pharmacists and chronic pain: A qualitative study of experience, perception, and challenges. Can J Pain. 2020;4(3):29–39.

Fernandez H, Cooke M, Patel T. Epilepsy and lifestyle behaviors related to bone health. Epilepsia. 2019;60(11):2306–13.

Fernandez H, Mohammed HT, Patel T. Vitamin D supplementation for bone health in adults with epilepsy: A systematic review. Epilepsia. 2018;59(4):885–96.


Foong A-L, Grindrod KA, Patel T, Kellar J. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician. 2018;64(10):720–7.


Foong A-L, Patel T, Kellar J, Grindrod KA. The scoop on serotonin syndrome. Can Pharm J. 2018;151(4):233–9.

Lee L, Patel T, Molnar F, Seitz D. Optimizing medications in cognitively impaired older adults: considerations for primary care clinician. Can Fam Physician. 2018;64(9):646–52.


Cheng R, Yang Y, Chan M, Patel T. Medication incidents involving antiepileptic drugs in Canadian hospitals: A multi-incident analysis. Healthcare Q. 2017;20(2):54–62.

Duong S, Patel T, Chang F. Dementia: What pharmacists need to know. Can Pharm J. 2017;150(2):118–29.

Maximos M, Chang F, Patel T. Risk of falls associated with antiepileptic drug use in ambulatory elderly populations. Can Pharm J. 2017;150(2):101–11.

Patel T, Slonim K, Lee L. Use of potentially inappropriate medications among ambulatory home-dwelling elderly patients with dementia: A review of the literature. Can Pharm J. 2017;150(3):169–83.

Patel T, Chang F, Mohammed HT, Raman-Wilms L, Jurcic J, Khan A, et al. Knowledge, perceptions, and attitudes toward chronic pain and Its arrangement: A cross-sectional survey of frontline pharmacists in Ontario. PLOS One. 2016;11(6).


Patel T, Milligan J, Lee J. Medication-related problems in individuals with spinal cord injury in a primary care-based clinic. J Spinal Cord Med. 2016;40(1):54–61.

Chang F, Patel T, Schulz ME. The “Rising Tide” of dementia in Canada: What does it mean for pharmacists and the people they care for? Can Pharm J. 2015;148(4):193–9.

Patel T, Chang F. Practice recommendations for Parkinson’s disease: Assessment and management by community pharmacists. Can Pharm J. 2015;148(3):142–9.

Patel T, Chang F. Parkinson’s disease guidelines for pharmacists. Can Pharm J. 2014;147(3):161–70.

Rojas-Fernandez CH, Patel T, Lee L. An interdisciplinary memory clinic: A novel practice setting for pharmacists in primary care. Ann Pharmacother. 2014;48(6):785–95.  

Seymour N, Patel T, Dixon H. Worsening of Myasthenia Gravis following the addition of Gabapentin for Essential Tremor. J Pharm Technol. 2013;29(4):191–3.

Patel T, Loewen PS. Should the window for intravenous administration of Tissue Plasminogen Activator in the treatment of Acute Ischemic Stroke be extended to 4.5 hours? Can J Hosp Pharm. 2009;62(3).

Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42(1):33–58.

Patel T, Radomski KM, Chandler MH. Assay Interaction between Oxaprozin and Phenytoin. Ann Pharmacother. 1997;31(2):254.

bottom of page